RARE | | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | CBO & EVP | Mar 11, 2024 | Sale | $49.93 | 11,509 | 574,644 | 252,823 | Mar 12, 2024, 01:41 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Fust Matthew K | Director | Mar 07, 2024 | Sale | $50.88 | 12,195 | 620,443 | 24,505 | Mar 11, 2024, 12:54 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and Chief Legal Officer | Mar 01, 2024 | Sale | $53.76 | 3,756 | 201,923 | 67,340 | Mar 05, 2024, 08:22 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | CBO & EVP | Mar 01, 2024 | Sale | $53.75 | 1,285 | 69,062 | 265,343 | Mar 05, 2024, 08:19 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | See Remarks | Mar 01, 2024 | Option Exercise | $53.69 | 470 | 25,234 | 83,002 | Mar 05, 2024, 08:17 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | Mar 01, 2024 | Sale | $53.76 | 4,233 | 227,562 | 93,441 | Mar 05, 2024, 08:15 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | Mar 01, 2024 | Option Exercise | $53.74 | 462 | 24,829 | 41,721 | Mar 05, 2024, 08:13 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Crombez Eric | EVP and Chief Medical Officer | Mar 01, 2024 | Sale | $53.76 | 1,238 | 66,555 | 48,927 | Mar 05, 2024, 08:10 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | Mar 01, 2024 | Sale | $53.76 | 4,768 | 256,328 | 67,163 | Mar 05, 2024, 08:08 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | Mar 01, 2024 | Option Exercise | $53.69 | 17,417 | 935,119 | 560,781 | Mar 05, 2024, 08:06 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | Feb 07, 2024 | Sale | $45.00 | 30,000 | 1,350,000 | 539,770 | Feb 08, 2024, 03:49 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | Dec 29, 2023 | Sale | $47.87 | 30,000 | 1,436,100 | 569,770 | Jan 02, 2024, 04:07 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | Jan 02, 2024 | Option Exercise | $21.00 | 3,000 | 63,000 | 27,892 | Jan 02, 2024, 04:06 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | CBO & EVP | Oct 23, 2023 | Option Exercise | $19.82 | 79,756 | 1,580,764 | 286,738 | Oct 24, 2023, 05:22 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | Oct 19, 2023 | Option Exercise | $20.19 | 95,706 | 1,932,304 | 647,029 | Oct 23, 2023, 05:14 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | Sep 07, 2023 | Sale | $31.29 | 4,163 | 130,249 | 25,777 | Sep 11, 2023, 01:52 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | Sep 05, 2023 | Sale | $37.96 | 6,000 | 227,760 | 51,281 | Sep 06, 2023, 05:51 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | Sep 01, 2023 | Sale | $37.15 | 970 | 36,032 | 23,864 | Sep 06, 2023, 05:50 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Sanders Corazon (Corsee) D. | Director | Jun 30, 2023 | Sale | $46.76 | 585 | 27,355 | 8,985 | Jun 30, 2023, 02:34 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | Jun 19, 2023 | Sale | $48.20 | 305 | 14,701 | 57,281 | Jun 21, 2023, 06:17 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Fust Matthew K | Director | Jun 07, 2023 | Option Exercise | $51.82 | 3,300 | 171,006 | 27,055 | Jun 09, 2023, 02:32 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Sanders Corazon (Corsee) D. | Director | Jun 08, 2023 | Sale | $51.65 | 1,485 | 76,700 | 9,570 | Jun 09, 2023, 02:31 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | May 18, 2023 | Sale | $50.00 | 2,012 | 100,600 | 74,744 | May 19, 2023, 01:54 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | May 09, 2023 | Option Exercise | $21.00 | 3,000 | 63,000 | 30,747 | May 10, 2023, 08:09 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and Chief Legal Officer | May 04, 2023 | Sale | $45.00 | 4,378 | 197,010 | 51,982 | May 05, 2023, 02:16 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | Apr 16, 2023 | Option Exercise | $38.20 | 195 | 7,449 | 27,701 | Apr 18, 2023, 04:57 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Bedrosian Camille L | EVP and Chief Medical Officer | Mar 01, 2023 | Sale | $45.25 | 3,881 | 175,615 | 46,720 | Mar 03, 2023, 08:00 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and Chief Legal Officer | Mar 01, 2023 | Sale | $45.25 | 3,161 | 143,035 | 56,139 | Mar 03, 2023, 07:59 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | CBO & EVP | Mar 01, 2023 | Sale | $45.51 | 5,362 | 244,027 | 250,254 | Mar 03, 2023, 07:57 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | Mar 01, 2023 | Sale | $45.65 | 1,433 | 65,416 | 23,048 | Mar 03, 2023, 07:54 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | See Remarks | Mar 01, 2023 | Sale | $45.65 | 10,988 | 501,602 | 75,314 | Mar 03, 2023, 07:53 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | Mar 01, 2023 | Sale | $45.46 | 7,769 | 353,190 | 80,174 | Mar 03, 2023, 07:53 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | Mar 01, 2023 | Option Exercise | $45.65 | 16,140 | 736,791 | 599,176 | Mar 03, 2023, 07:52 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | Mar 01, 2023 | Sale | $45.25 | 3,664 | 165,796 | 57,344 | Mar 03, 2023, 07:51 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | Feb 28, 2023 | Sale | $43.40 | 639 | 27,733 | 15,558 | Mar 02, 2023, 02:28 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | Dec 30, 2022 | Sale | $45.57 | 19,582 | 892,352 | 541,108 | Jan 03, 2023, 04:45 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | Dec 21, 2022 | Sale | $43.96 | 2,031 | 89,283 | 16,197 | Dec 22, 2022, 01:24 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Dier Mardi | CFO & Executive Vice President | Oct 14, 2022 | Sale | $40.16 | 1,629 | 65,421 | 66,695 | Oct 17, 2022, 06:49 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Dier Mardi | CFO & Executive Vice President | Oct 12, 2022 | Sale | $38.22 | 3,484 | 133,158 | 68,324 | Oct 14, 2022, 12:58 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | Jun 19, 2022 | Sale | $54.78 | 295 | 16,160 | 36,160 | Jun 22, 2022, 07:27 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | Apr 16, 2022 | Sale | $84.55 | 132 | 11,161 | 16,914 | Apr 19, 2022, 12:56 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | CBO & EVP | Mar 11, 2022 | Sale | $67.01 | 10,281 | 688,930 | 227,559 | Mar 15, 2022, 04:33 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and Chief Legal Officer | Mar 07, 2022 | Sale | $62.95 | 5,140 | 323,563 | 34,438 | Mar 08, 2022, 12:25 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Fust Matthew K | Director | Mar 04, 2022 | Option Exercise | $40.37 | 7,500 | 302,775 | 23,195 | Mar 08, 2022, 12:25 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Dier Mardi | CFO & Executive Vice President | Mar 01, 2022 | Sale | $66.62 | 534 | 35,575 | 38,228 | Mar 03, 2022, 06:12 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Dier Mardi | CFO & Executive Vice President | Mar 03, 2022 | Sale | $64.55 | 420 | 27,111 | 51,808 | Mar 03, 2022, 06:12 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | Mar 01, 2022 | Sale | $66.62 | 2,713 | 180,740 | 22,317 | Mar 03, 2022, 06:11 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | Mar 01, 2022 | Sale | $66.62 | 4,498 | 299,657 | 45,266 | Mar 03, 2022, 06:10 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | Mar 01, 2022 | Sale | $66.62 | 843 | 56,161 | 13,229 | Mar 03, 2022, 06:09 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | See Remarks | Mar 01, 2022 | Sale | $66.62 | 3,234 | 215,449 | 36,914 | Mar 03, 2022, 06:09 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and Chief Legal Officer | Mar 01, 2022 | Sale | $66.62 | 2,886 | 192,265 | 25,472 | Mar 03, 2022, 06:08 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | CBO & EVP | Mar 01, 2022 | Sale | $66.62 | 2,374 | 158,156 | 213,840 | Mar 03, 2022, 06:07 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Bedrosian Camille L | EVP and Chief Medical Officer | Mar 01, 2022 | Sale | $66.62 | 2,821 | 187,935 | 33,938 | Mar 03, 2022, 06:07 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | Mar 01, 2022 | Option Exercise | $67.37 | 12,162 | 819,354 | 582,185 | Mar 03, 2022, 06:06 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Bedrosian Camille L | EVP and Chief Medical Officer | Jan 30, 2022 | Sale | $66.30 | 1,657 | 109,859 | 36,759 | Feb 01, 2022, 01:39 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Bedrosian Camille L | EVP and Chief Medical Officer | Oct 14, 2021 | Sale | $81.14 | 359 | 29,129 | 38,416 | Oct 18, 2021, 07:02 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | Oct 14, 2021 | Sale | $81.14 | 303 | 24,585 | 25,030 | Oct 18, 2021, 06:58 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | EVP & Chief Tech Ops Officer | Oct 14, 2021 | Sale | $81.14 | 358 | 29,048 | 40,148 | Oct 18, 2021, 06:55 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | Oct 14, 2021 | Sale | $81.14 | 140 | 11,360 | 14,072 | Oct 18, 2021, 06:53 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | CBO & EVP | Oct 14, 2021 | Sale | $81.14 | 286 | 23,206 | 216,266 | Oct 18, 2021, 06:48 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and General Counsel | Oct 14, 2021 | Sale | $81.14 | 310 | 25,153 | 28,358 | Oct 18, 2021, 06:46 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | Oct 14, 2021 | Option Exercise | $81.00 | 853 | 69,093 | 594,347 | Oct 18, 2021, 06:44 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | Oct 14, 2021 | Sale | $81.14 | 358 | 29,048 | 49,764 | Oct 18, 2021, 06:41 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Dier Mardi | CFO & Executive Vice President | Oct 12, 2021 | Sale | $82.79 | 3,477 | 287,861 | 42,023 | Oct 14, 2021, 06:33 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Dier Mardi | CFO & Executive Vice President | Oct 14, 2021 | Sale | $81.16 | 3,261 | 264,663 | 38,762 | Oct 14, 2021, 06:33 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | CBO & EVP | Sep 30, 2021 | Option Exercise | $0.31 | 109,734 | 34,018 | 216,552 | Oct 01, 2021, 12:57 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and General Counsel | Sep 08, 2021 | Option Exercise | $77.58 | 14,672 | 1,138,180 | 36,004 | Sep 09, 2021, 06:22 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Bedrosian Camille L | EVP and Chief Medical Officer | Sep 02, 2021 | Sale | $77.59 | 5,000 | 387,950 | 41,275 | Sep 02, 2021, 06:11 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Bedrosian Camille L | EVP and Chief Medical Officer | Sep 01, 2021 | Sale | $77.51 | 5,000 | 387,575 | 41,275 | Sep 02, 2021, 06:11 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | Jul 06, 2021 | Sale | $91.53 | 375 | 34,324 | 25,333 | Jul 08, 2021, 11:56 AM |
RARE | | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | Jun 19, 2021 | Sale | $94.63 | 437 | 41,353 | 26,280 | Jun 23, 2021, 05:55 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | Jun 21, 2021 | Sale | $94.96 | 572 | 54,317 | 25,708 | Jun 23, 2021, 05:55 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | EVP & Chief Tech Ops Officer | May 06, 2021 | Sale | $113.68 | 363 | 41,266 | 40,506 | May 10, 2021, 06:14 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and General Counsel | May 06, 2021 | Sale | $113.67 | 313 | 35,579 | 29,997 | May 10, 2021, 06:13 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | May 06, 2021 | Sale | $113.69 | 363 | 41,269 | 50,122 | May 10, 2021, 06:13 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | CBO & EVP | May 06, 2021 | Sale | $113.69 | 363 | 41,269 | 106,818 | May 10, 2021, 06:11 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | May 06, 2021 | Option Exercise | $115.71 | 852 | 98,585 | 595,200 | May 10, 2021, 06:11 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | May 03, 2021 | Sale | $107.80 | 30,000 | 3,234,000 | 2,259,741 | May 05, 2021, 11:32 AM |
RARE | | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | Apr 20, 2021 | Sale | $104.28 | 396 | 41,295 | 27,417 | Apr 21, 2021, 08:07 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Controller and PAO | Mar 08, 2021 | Sale | $120.69 | 3,000 | 362,070 | 13,544 | Mar 09, 2021, 12:37 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | CBO & EVP | Mar 01, 2021 | Sale | $138.17 | 4,572 | 631,713 | 107,181 | Mar 03, 2021, 08:55 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | Mar 01, 2021 | Sale | $138.17 | 6,198 | 856,378 | 50,237 | Mar 03, 2021, 08:48 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and General Counsel | Mar 01, 2021 | Sale | $138.17 | 3,970 | 548,535 | 30,227 | Mar 03, 2021, 08:47 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Controller and PAO | Mar 01, 2021 | Sale | $138.17 | 732 | 101,140 | 16,544 | Mar 03, 2021, 08:43 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | Mar 01, 2021 | Sale | $138.17 | 2,470 | 341,280 | 28,520 | Mar 03, 2021, 08:42 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | Mar 02, 2021 | Sale | $138.16 | 707 | 97,679 | 27,813 | Mar 03, 2021, 08:42 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | EVP & Chief Tech Ops Officer | Mar 01, 2021 | Sale | $138.18 | 4,255 | 587,956 | 40,761 | Mar 03, 2021, 08:39 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Bedrosian Camille L | EVP and Chief Medical Officer | Mar 01, 2021 | Sale | $138.18 | 4,543 | 627,752 | 39,139 | Mar 03, 2021, 08:37 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | Mar 01, 2021 | Sale | $141.80 | 30,000 | 4,254,000 | 2,289,741 | Mar 03, 2021, 08:36 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | Mar 01, 2021 | Option Exercise | $142.47 | 16,342 | 2,328,245 | 596,052 | Mar 03, 2021, 08:36 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Aliski William | Director | Feb 19, 2021 | Sale | $123.43 | 15,000 | 1,851,450 | 73,204 | Feb 23, 2021, 02:30 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | Jun 03, 2020 | Sale | $74.69 | 2,516 | 187,920 | 20,854 | Feb 03, 2021, 08:04 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Bedrosian Camille L | EVP and Chief Medical Officer | Jan 30, 2021 | Sale | $140.36 | 2,243 | 314,827 | 33,546 | Feb 02, 2021, 04:28 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Bedrosian Camille L | EVP and Chief Medical Officer | Jan 15, 2021 | Sale | $97.09 | 50,000 | 4,854,500 | 60,789 | Jan 19, 2021, 04:01 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Controller and PAO | Jan 07, 2021 | Sale | $80.82 | 8,000 | 646,600 | 20,436 | Jan 08, 2021, 07:05 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | Jan 04, 2021 | Sale | $136.90 | 30,000 | 4,107,000 | 2,329,741 | Jan 05, 2021, 06:45 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | Nov 02, 2020 | Sale | $96.82 | 30,000 | 2,904,600 | 2,359,741 | Nov 04, 2020, 03:44 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and General Counsel | Oct 30, 2020 | Option Exercise | $77.31 | 19,806 | 1,531,202 | 33,871 | Nov 02, 2020, 05:05 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and General Counsel | Oct 28, 2020 | Option Exercise | $77.25 | 194 | 14,987 | 24,065 | Oct 30, 2020, 05:28 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | Oct 14, 2020 | Option Exercise | $92.69 | 852 | 78,972 | 610,189 | Oct 16, 2020, 07:23 PM |